Mastek Grants 6 Lakh Options Under ESOP Plans VI & VII
Mastek Limited announced the grant of 6,00,000 stock options to employees under ESOP Plans VI and VII, effective April 1, 2026. The exercise price is ₹1,000 per option, with vesting occurring over three years based on performance conditions.
Granting stock options to employees is a routine HR and compensation activity. While it can aid in employee retention and motivation, its direct financial impact on the company's overall performance is typically marginal and long-term.
The announcement pertains to the grant of employee stock options, which is a standard corporate practice and does not inherently indicate a positive or negative development for the company's financial performance.
Mastek Limited has announced the grant of 6,00,000 (Six Lakhs) stock options to eligible employees under its ESOP Plan VI and Plan VII. The effective date for this grant is April 1, 2026. Each option will have an exercise price of ₹1,000.
The vesting of these options is scheduled to occur over the 3rd, 4th, and 5th years following the grant date. Vesting is contingent upon the fulfillment of pre-set performance conditions determined by the Nomination and Remuneration Committee. If performance conditions are not met by the first vesting date, unvested options may vest on the subsequent vesting dates, subject to meeting the conditions. Any options remaining unvested after the third vesting date will lapse. The exercise period for vested options is a maximum of 7 years from the vesting date.
The grant is in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the SEBI (Share Based Employee Benefits) Regulations, 2021.
What to do with a filing like this
Mastek Limited filed this with the NSE as a statutory disclosure, categorised under designated person disclosures. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Mastek Limited. Read the original for the full detail.